What is FreezeM?
FreezeM is at the forefront of enhancing insect farming efficiency through its innovative Black Soldier Fly (BSF) breeding solutions. The company provides life-cycle paused BSF neonates globally, leveraging patented technologies to facilitate high-performing larvae production. This approach significantly reduces operational costs and boosts protein yield for its clients. FreezeM offers flexible and scalable solutions for both in-house and outsourced breeding operations, catering to a diverse range of production scales. Furthermore, the company plays a crucial role in waste management by enabling the conversion of bio-waste into valuable protein, thereby promoting sustainable practices across various industries.
How much funding has FreezeM raised?
FreezeM has raised a total of $14.2M across 1 funding round:
Series A
$14.2M
Series A (2024): $14.2M with participation from investor European Innovation Council Fund
Key Investors in FreezeM
investor European Innovation Council Fund
The European Innovation Council Fund is a prominent investor likely focused on supporting innovative European companies with significant growth potential, particularly in sectors aligned with sustainability and technological advancement.
What's next for FreezeM?
The recent major strategic investment in FreezeM signals a pivotal growth phase for the company, likely enabling expansion of its breeding capabilities and global reach. This capital infusion is expected to accelerate the development and deployment of its BSF breeding technologies, further solidifying its position in the burgeoning insect farming and sustainable protein markets. FreezeM's focus on cost reduction and increased protein yield, coupled with its waste-to-protein solutions, positions it as a key player in addressing both food security and environmental sustainability challenges.
See full FreezeM company page
